HBM Healthcare Investments AG

HBM Healthcare Investments AG is a Swiss investment company specializing in investments across the global healthcare sector. Its primary function is to build and manage a diversified portfolio that includes both private and publicly listed companies focused on biotechnology, medical technology, diagnostics, and digital health. With a dedicated team of investment professionals and a network of external advisors, the company seeks out growth-oriented businesses that have demonstrated proof of concept or significant clinical and regulatory milestones before investment. HBM Healthcare Investments AG provides shareholders access to a broad spectrum of healthcare innovations, with investments spanning North and South America, Europe, and Asia. The portfolio is structured to balance growth opportunities and risk, using private equity and partial hedging against market and currency fluctuations. Since its inception, the company has played a pivotal role in the development and commercialization of next-generation medical treatments, supporting emerging leaders in fields such as oncology, central nervous system disorders, immunology, and orphan diseases, among others. Its track record features numerous successful trade sales and IPOs, underlining its position as a key player in global healthcare investment.